- 全部删除
您的购物车当前为空
SMU-L11 是一种特异性 TLR7 激动剂 (EC50=0.024 μM),能够招募 MyD88 接头蛋白并激活 NF-κB 和 MAPK 信号通路。在小鼠模型中,SMU-L11 显著增强免疫细胞激活,并促进 CD4+T 和 CD8+T 细胞增殖,从而直接杀死肿瘤细胞并抑制肿瘤增长。SMU-L11 可用于癌症研究,并具有研究免疫系统疾病的潜力。
SMU-L11 是一种特异性 TLR7 激动剂 (EC50=0.024 μM),能够招募 MyD88 接头蛋白并激活 NF-κB 和 MAPK 信号通路。在小鼠模型中,SMU-L11 显著增强免疫细胞激活,并促进 CD4+T 和 CD8+T 细胞增殖,从而直接杀死肿瘤细胞并抑制肿瘤增长。SMU-L11 可用于癌症研究,并具有研究免疫系统疾病的潜力。

SMU-L11 相关产品
| 产品描述 | SMU-L11 is a specific TLR7 agonist (EC50=0.024 μM) that recruits the MyD88 adaptor protein, activating downstream NF-κB and MAPK signaling pathways. In mouse models, SMU-L11 significantly enhances immune cell activation and boosts CD4+ T and CD8+ T cell proliferation, leading to direct tumor cell destruction and inhibition of tumor growth. This compound has applications in cancer research and potential in studying immune system disorders. |
| 靶点活性 | TLR7:0.024 μM (EC50) |
| 分子式 | C19H24N4O |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容